Skip to main content
menu sluit menu
Home Home
Login
Main navigation
  • Library
  • Calendar
  • e-Learning
  • News
    • Veterinary News In this section you find veterinary news
    • Recent Additions All content that was recently added to the IVIS library
  • Get involved
    • Donate Support IVIS, make a donation today
    • Media kit Promote your e-learning & events on IVIS
    • Add your e-learning & events to the IVIS calendar
    • Publish on IVIS Publish your work with us
  • About
    • Mission Our Mission Statement
    • What we do More info about IVIS and what we do
    • Who we are More info about the IVIS team
    • Authors See list of all IVIS authors and editors
  • Contact
User tools menu
User tools menu
Main navigation
  • Library
  • Calendar
  • e-Learning
  • News
    • Veterinary News In this section you find veterinary news
    • Recent Additions All content that was recently added to the IVIS library
  • Get involved
    • Donate Support IVIS, make a donation today
    • Media kit Promote your e-learning & events on IVIS
    • Add your e-learning & events to the IVIS calendar
    • Publish on IVIS Publish your work with us
  • About
    • Mission Our Mission Statement
    • What we do More info about IVIS and what we do
    • Who we are More info about the IVIS team
    • Authors See list of all IVIS authors and editors
  • Contact
Follow IVIS
  • Twitter
  • Facebook
Support IVIS

Breadcrumb

  1. Home
  2. Library
  3. Encyclopedia of Canine Clinical Nutrition
  4. Clinical Consequences of Uremia
Encyclopedia of Canine Clinical Nutrition
Back to Table of Contents
Add to My Library
Close
Would you like to add this to your library?

Get access to all handy features included in the IVIS website

  • Get unlimited access to books, proceedings and journals.
  • Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
  • Bookmark your favorite articles in My Library for future reading.
  • Save future meetings and courses in My Calendar and My e-Learning.
  • Ask authors questions and read what others have to say.
Sign in Register
Comments
Print this article
Share:
  • Facebook
  • LinkedIn
  • Mail
  • Twitter

Clinical Consequences of Uremia

Author(s):
Elliott D.A. and
Lefebvre H.
In: Encyclopedia of Canine Clinical Nutrition by Pibot P. et al.
Updated:
JUN 03, 2008
Languages:
  • DE
  • EN
  • ES
  • FR
  • IT
Back to Table of Contents
Add to My Library
Close
Would you like to add this to your library?

Get access to all handy features included in the IVIS website

  • Get unlimited access to books, proceedings and journals.
  • Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
  • Bookmark your favorite articles in My Library for future reading.
  • Save future meetings and courses in My Calendar and My e-Learning.
  • Ask authors questions and read what others have to say.
Sign in Register
Print this article
SHARE:
  • Facebook
  • LinkedIn
  • Mail
  • Twitter
    Read

    3. Clinical Consequences of Uremia

    Gastrointestinal Consequences

    Gastrointestinal intoxications including anorexia, nausea, vomiting, fetid breath, stomatitis, oral ulcerations colitis, diarrhea, intussusception and ileus are the most common and prominent clinical signs of uremia. These lesions and dysfunctions act singularly or in concert to induce gastrointestinal pathology.

    Excess urea secreted in salivary and gastric juices is converted by urease producing bacteria to ammonia that directly damages the mucosa. Uremic toxins also injure the gastric mucus, mucosa, submucosa or vasculature, thereby reducing the protection afforded by the gastric mucosal barrier. Reduced renal clearance of gastrin leads to hypergastrinemia and stimulation of gastric acid production.

    Increased diffusion of acid into the gastric wall induces inflammation, ulceration, and hemorrhage, in addition to perpetuating uremic toxin induced gastric injury. Vomiting occurs secondary to gastritis in addition to the direct effect of uremic toxins on the chemoreceptor trigger zone.

    Oral lesions in uremic stomatitis/gingivitis
    Figure 5. Oral lesions in uremic stomatitis/gingivitis. (© DJ Chew).

    Neuromuscular Consequences

    The two major neurologic complications of uremia are uremic encephalopathy and neuropathy. Uremic encephalopathy is a term that reflects diffuse and non specific alterations of the cerebral cortex. The severity and progression of the neurological signs is generally correlated with the magnitude and progression of the azotemia. Typical signs include a progressive decline in alertness and awareness, dullness, lethargy, impaired mentation, altered behavior, confusion, stupor, tremors, ataxia, muscular cramps, fatigue, muscle weakness, seizures and coma. The neurological signs are due to the effects of uremic toxins, hyperparathyroidism, hypocalcemia, hypokalemia and hypertension.

    The Doppler technique and oscillometry are very common methods for detecting hypertension
    The Doppler technique and oscillometry are very common methods for detecting hypertension. Doppler is the recommended technique for cats. The oscillometric measurements in dogs can be unreliable due to differences in conformation, obesity or a thick coat (
    Stepien, 2001). The animal’s adaptation to the environment is critical to the interpretation of arterial pressure measurements, as stress can induce erroneous results. Six to ten measurements are recommended. (© J-C Meauxsoone).

    The Doppler technique and oscillome try are very common methods for detecting hypertension. Doppler is the recommended technique for cats. The oscillometric measurements in dogs can be unreliable due to differences in conformation, obesity or a thick coat (Stepien, 2001). The animal's adaptation to the environment is critical to the interpretation of arterial pressure measurements, as stress can induce erroneous results. Six to ten measurements are recommended.

    Cardiopulmonary Consequences

    Cardiopulmonary complications include hypertension, uremic cardiomyopathy, uremic pericarditis, pulmonary edema and uremic pneumonitis. Abnormalities in fluid, electrolyte and acid base balance may contribute to alterations in cardiac contractility and excitability. Azotemia and overhydration play a role in pericarditis, uremic cardiomyopathy and pulmonary edema. Hypertension arises secondary to a combination of activation of the renin-angiotensin aldosterone system, sodium retention, plasma volume expansion, activation of the sympathetic nervous system, decreased activity of vasodilatory substances, increased cardiac output, increased total peripheral vascular resistance and secondary hyperparathyroidism. Systemic hypertension predominately targets the kidneys (glomerulosclerosis), heart (left ventricular hypertrophy, myocardial ischemia), eyes (retinal detachment, hyphema, retinal hemorrhage) and brain (hypertensive encephalopathy, dementia, cerebrovascular hemorrhage). Uremic pneumonitis refers to the formation of a high protein pulmonary edema which is presumably a consequence of uremic toxins damaging alveoli and increasing capillary permeability.

    Ocular Consequences

    Common manifestations of advanced uremia include scleral and conjunctival injection and ocular pathology secondary to systemic hypertension. Opthalmoscopic findings include reduced pupillary light reflexes, papilledema, retinal arterial tortuosity, retinal hemorrhage, retinal detachment, hyphema, anterior uveitis and glaucoma. Ischemia and retinal degeneration result from sustained retinal arteriolar vasoconstriction which is an attempt to auto-regulate local blood flow in the face of sustained chronic hypertension.

    Metabolic and Endocrine Consequences

    The kidney is responsible for the degradation of many peptide hormones and loss of this catabolic function can result in metabolic derangements caused by hormone excess. Deranged insulin metabolism may also contribute to hyperlipidemia. Other hormonal alterations include increased concentrations of gastrin, glucagon, growth hormone, prolactin and luteinizing hormone. Serum T4 concentrations are low and there is impairment in the conversion of T4 to T3 (euthyroid sick syndrome).

    Fluid, Electrolyte and Acid-base Consequences

    Metabolic acidosis is a frequent finding in renal disease and results primarily from the inability of the kidney to excrete hydrogen ions and regenerate bicarbonate. Chronic acidosis causes progressive bone demineralization, urinary calcium loss, hypokalemia and increases skeletal muscle protein catabolism which exacerbates azotemia.

    Hyperphosphatemia is one of the most common regulatory derangements of CRF that arises secondary to reduced glomerular filtration of phosphorus. Hyperphosphatemia contributes to renal secondary hyperparathyroidism (see below), reduced calcitriol levels, soft tissue calcification, renal osteodystrophy and hypocalcemia. Soft tissue mineralization develops as the calcium x phosphate product exceeds 60 (concentrations are expressed in mg/dL).The most commonly targeted organs include the gastric mucosa, bronchial walls, myocardium, endocardium, renal interstitium, glomeruli, lungs, and intercostal muscles. Renal mineralization will promote interstitial inflammation, fibrosis and progression of renal failure.

    Hypokalemia is a common abnormality associated with chronic renal failure. The mechanism is unclear and includes excessive urinary potassium loss, inadequate dietary potassium intake, and acidifying diets. Hypokalemia causes generalized muscle weakness and pain which may present as cervical ventroflexion and a stiff, stilted gait. Hypokalemia also impairs protein synthesis, promotes weight loss, a poor hair coat and contributes to polyuria by decreasing the renal responsiveness to ADH. Chronic potassium depletion may indeed impair renal function by inducing a reversible, functional decline in GFR in addition to promoting renal injury by enhancing ammoniagenesis.

    Renal Secondary Hyperparathyroidism

    Renal secondary hyperparathyroidism is a clinical syndrome that is characterized by increased secretion of parathyroid hormone (PTH). PTH secretion is stimulated by hypocalcemia and decreased plasma calcitriol concentrations. Hypocalcemia is a mass action (i.e. calcium x phosphate remains constant) consequence of renal retention of phosphate.

    Calcitriol production is regulated at the level of the 1-α-hydroxylase enzyme in the kidney. Phosphate in excess and loss of functional renal mass result in a decrease in 1-α-hydroxylase activity and reduces the conversion of 25-dihydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 (calcitriol). Calcitriol deficiency reduces the intestinal absorption of calcium, reduces the release of calcium and phosphate from bone, reduces renal reabsorption of calcium and phosphate and increases the synthesis and release of PTH (Figure 6aand Figure 6b).

    Influence of PTH on the metabolism of calcium and of phosphorus
    Figure 6a. Influence of PTH on the metabolism of calcium and of phosphorus.  

    Mechanism of development of renal secondary hyperthyroidism in CRF
    Figure 6b. Mechanism of development of renal secondary hyperthyroidism in CRF.  

    Initially the increased PTH concentration activates the remaining 1-alpha hydroxylase enzyme with a compensatory increased in calcitriol concentrations. However, with disease progression stimulation of 1-α-hydroxylase becomes ineffectual and calcitriol concentrations remain low. Complications of renal secondary hyperparathyroidism include osteodystrophy, soft tissue calcification, skeletal decalcification, cystic bone lesions, bone pain and growth retardation. Osteodystrophy most commonly occurs in immature patients and is recognized by demineralization of the bones. The teeth become movable and the jaw can be bent or twisted without fracturing (rubber jaw). Facial distortion may occur secondary to connective tissue proliferation. PTH has also been implicated as a uremic toxin and may contribute to the progression of renal failure.

    Hematologic Consequences

    Normocytic normochromic non-regenerative anemia is the most common abnormality in uremia. The pathogenesis is multifactorial and includes inadequate production of erythropoietin by the diseased kidneys, reduced life span of red cells, nutritional deficiencies, uremic toxin induced inhibition of erythropoiesis and blood loss with consequent iron deficiency. Anemia will contribute to the clinical signs of lethargy and inappetance. Neutrophil function and cell mediated immunity is impaired in uremia, predisposing the uremic patient to infection. The specific causes of renal failure associated immunocompromise is not completely understood, although malnutrition, uremic toxins, PTH and vitamin D concentrations may be involved.

    The hydration state is evaluated by clinical examination, the measurement of hematocrit and total plasma proteins
    The hydration state is evaluated by clinical examination, the measurement of hematocrit and total plasma proteins. (© J-C Meauxsoone).

    Back to Table of Contents
    Add to My Library
    Close
    Would you like to add this to your library?

    Get access to all handy features included in the IVIS website

    • Get unlimited access to books, proceedings and journals.
    • Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
    • Bookmark your favorite articles in My Library for future reading.
    • Save future meetings and courses in My Calendar and My e-Learning.
    • Ask authors questions and read what others have to say.
    Sign in Register
    Print this article
    References

    1. Adams LG. Phosphorus, protein and kidney disease. Proceeding of the Petfood Forum 1995 (13-26).

    2. Bauer JE, Markwell PJ, Rawlings JM et al. Effects of dietary fat and polyunsaturated fatty acids in dogs with naturally developing chronic renal failure. J Am Vet Med Assoc 1999; 215: 1588-1591.

    ...
    Show all
    Comments (0)

    Ask the author

    0 comments
    Submit
    Close
    Would to like to further discuss this item?

    Get access to all handy features included in the IVIS website

    • Get unlimited access to books, proceedings and journals.
    • Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
    • Bookmark your favorite articles in My Library for future reading.
    • Save future meetings and courses in My Calendar and My e-Learning.
    • Ask authors questions and read what others have to say.
    Sign in Register
    About

    How to reference this publication (Harvard system)?

    Elliott, D. A. and Lefebvre, H. (2008) “Clinical Consequences of Uremia”, Encyclopedia of Canine Clinical Nutrition. Available at: https://www.ivis.org/library/encyclopedia-of-canine-clinical-nutrition/clinical-consequences-of-uremia (Accessed: 05 February 2023).

    Affiliation of the authors at the time of publication

    1Royal Canin USA, MO, USA. 2Experimental Physiopathology and Toxicology, National Veterinary School of Toulouse, Toulouse, France.

    Author(s)

    • Denise Elliott

      Elliott D.A.

      BVSc (Hons) PhD Dipl ACVIM Dipl ACVN
      Royal Canin USA, 500 Fountain Lakes Boulevard, Suite 100
      Read more about this author
    • Lefebvre H.

      DMV, PhD, Dipl ECVPT
      Experimental Physiopathology and Toxicology, National Veterinary School of Toulouse, 23 Chemin des Capelles
      Read more about this author

    Copyright Statement

    © All text and images in this publication are copyright protected and cannot be reproduced or copied in any way.
    Related Content

    Readers also viewed these publications

    • Journal Issue

      Veterinary Evidence - Vol 8 N°1, Jan-Mar 2023

      In: Veterinary Evidence
      JAN 28, 2023
    • Journal Issue

      Veterinary Evidence - Vol 7 N°4, Oct-Dec 2022

      In: Veterinary Evidence
      JAN 16, 2023
    • Proceeding

      SFT - Theriogenology Annual Conference - Bellevue, 2022

      By: Society for Theriogenology
      JAN 10, 2023
    • Journal Issue

      Urgencias y cuidados intensivos - Argos N°244, Diciembre 2022

      In: Argos
      DEC 31, 2022
    • Journal Issue

      Israel Journal of Veterinary Medicine - Vol. 77(4), Dec. 2022

      DEC 31, 2022
    • Proceeding

      ISCFR-EVSSAR Symposium - Italy 2022

      By: International Symposium on Canine and Feline Reproduction
      DEC 02, 2022
    • Journal Issue

      Patología endocrina - Argos N°243, Noviembre 2022

      In: Argos
      NOV 27, 2022
    • Proceeding

      ACVIM & ECEIM - Consensus Statements

      By: American College of Veterinary Internal Medicine
      NOV 11, 2022
    • Journal Issue

      Traumatología y neurología - Argos Nº242, Octubre 2022

      In: Argos
      NOV 10, 2022
    • Chapter

      Tibia and Tarsus

      In: Current Techniques in Small Animal Surgery (5th Edition)
      NOV 07, 2022
    • Chapter

      Femur and Stifle Joint

      In: Current Techniques in Small Animal Surgery (5th Edition)
      OCT 28, 2022
    • Journal Issue

      Medicina felina - Argos Nº241, Septiembre 2022

      In: Argos
      OCT 24, 2022
    • Chapter

      Sacroiliac Joint, Pelvis, and Hip Joint

      In: Current Techniques in Small Animal Surgery (5th Edition)
      OCT 17, 2022
    • Journal Issue

      Veterinary Evidence - Vol 7 N°2, Apr-Jun 2022

      In: Veterinary Evidence
      OCT 07, 2022
    • Journal Issue

      Veterinary Evidence - Vol 7 N°3, Jul-Sep 2022

      In: Veterinary Evidence
      OCT 04, 2022
    • Chapter

      Amputation of the Forelimb

      In: Current Techniques in Small Animal Surgery (5th Edition)
      OCT 02, 2022
    • Journal Issue

      Israel Journal of Veterinary Medicine - Vol. 77(3), Sep. 2022

      In: Israel Journal of Veterinary Medicine
      SEP 30, 2022
    • Chapter

      Carpus, Metacarpus, and Phalanges

      In: Current Techniques in Small Animal Surgery (5th Edition)
      SEP 26, 2022
    • Chapter

      Radius and Ulna

      In: Current Techniques in Small Animal Surgery (5th Edition)
      SEP 16, 2022
    • Chapter

      Humerus and Elbow Joint

      In: Current Techniques in Small Animal Surgery (5th Edition)
      SEP 10, 2022
    • Chapter

      Scapula and Shoulder Joint

      In: Current Techniques in Small Animal Surgery (5th Edition)
      SEP 05, 2022
    • Chapter

      Bone Grafts and Implants

      In: Current Techniques in Small Animal Surgery (5th Edition)
      SEP 03, 2022
    • Chapter

      External Skeletal Fixation

      In: Current Techniques in Small Animal Surgery (5th Edition)
      AUG 28, 2022
    • Chapter

      Plate-Rod Fixation

      In: Current Techniques in Small Animal Surgery (5th Edition)
      AUG 18, 2022
    • Chapter

      Fixation with Screws and Bone Plates

      In: Current Techniques in Small Animal Surgery (5th Edition)
      AUG 15, 2022
    • Load more
    Back To Top
    Become a member of IVIS and get access to all our resources
    Create an account
    Sign in
    Leading the way in providing veterinary information
    About IVIS
    • Mission
    • What we do
    • Who we are
    Need help?
    • Contact
    Follow IVIS
    • Twitter
    • Facebook
    International Veterinary Information Service (IVIS) is a not-for-profit organization established to provide information to veterinarians, veterinary students, technicians and animal health professionals worldwide using Internet technology.
    Support IVIS
    © 2023 International Veterinary Information Service
    • Disclaimer
    • Privacy Policy